KBMO Diagnostics (FIT Test)

KBMO Diagnostics is a fully integrated medical diagnostics company headquartered in Hopedale, Massachusetts, specializing in food sensitivity and inflammation testing. Established in 2004, the company focuses on personalized medicine through advanced diagnostic testing that helps practitioners identify individual food triggers and gut health patterns. Their core offering, the patented FIT Test, measures immune responses to foods and additives using a multi-pathway approach that detects both IgG antibodies and Immune Complexes simultaneously, providing what the company describes as the most sensitive food sensitivity test available.

The FIT Test comes in two versions: FIT 176 (measuring sensitivities to 176 foods and additives) and FIT 132 (measuring 132 foods and additives). Both now include the Gut Barrier Panel, which assesses gastrointestinal permeability and barrier function. Available as blood spot or serum tests, these assessments provide practitioners with actionable data to tailor individualized treatment plans. Beyond testing, KBMO offers personalized nutritionist support, including customized 7-day meal plans based on individual results.

KBMO operates an FDA-registered, ISO 13485-compliant manufacturing facility and maintains a CLIA High Complexity Laboratory. The company's testing methodology was developed by Chief Scientific Officer Brent Dorval, PhD, who brings over 25 years of experience in medical device research and diagnostics, including previous work on rapid diagnostic assays. This combination of rigorous regulatory compliance, patented technology, and clinical expertise positions KBMO as a resource for practitioners seeking precise food sensitivity data to support patient health optimization.